(Press-News.org) Mount Sinai researchers have identified a cellular mechanism linking infections from influenza A viruses (IAVs) to cardiovascular disease, providing critical insights on how influenza can damage the heart and increase the risk of a heart attack or other major cardiovascular event.
Through its work with mouse models and human data, the team also provided evidence that a cutting-edge modified mRNA treatment that dampens an interferon signaling pathway in the heart can significantly mitigate cardiac damage following viral infection while preserving the protective antiviral response of the immune system. The study was published in the February 9 issue of Immunity.
“We have known for years that the frequency of heart attacks increases during flu season, yet outside of clinical intuition, scant evidence exists of the underlying mechanisms of that phenomenon,” says Filip Swirski, PhD, Director of the Cardiovascular Research Institute at the Icahn School of Medicine at Mount Sinai and the senior author of the study. “Studies like ours are now shedding valuable light on immune system pathways, like the antiviral cytokine type 1 interferon (IFN-1), that factor into damage to the heart following severe influenza infection. These findings offer great promise for the development of new therapies, which are desperately needed since there are currently no viable clinical options to prevent cardiac damage.”
Influenza A viruses are responsible for an estimated 1 billion infections globally each year, ranging from seasonal flu outbreaks locally to pandemics globally. While most infections are mild and self-resolving, in some cases they can become severe or even fatal, particularly when the virus travels to the heart and triggers the death of cardiomyocytes, specialized muscle cells that are responsible for the rhythmic contraction and relaxation of the heart.
The Mount Sinai team studied autopsies of 35 hospitalized patients who died of influenza and found that more than 85 percent had at least one significant cardiovascular comorbidity, such as hypertension, and that the majority had multiple comorbidities, including atherosclerosis and cardiac fibrosis, underscoring cardiovascular disease as a major driver of influenza mortality.
The research team also uncovered the mechanism by which cardiac damage occurs. They learned, for example, that a novel subset of white blood cells, known as pro-dendritic cell 3, becomes infected in the lung and, after traveling to the heart, produces large amounts of type 1 interferon. This, instead of fulfilling its mission of clearing the virus from the heart, triggers the death of cardiomyocytes, impairing cardiac output.
“We found that the pro-dendritic cell 3 acts as the ‘Trojan horse’ of the immune system during influenza infection, becoming infected in the lung, trafficking the virus to the heart, and disseminating it to cardiomyocytes. This process causes production of the damaging type 1 interferon that comes with considerable collateral damage to the heart,” explains Jeffrey Downey, PhD, a member of Dr. Swirski’s laboratory who served as lead author of the study. “The hopeful news for patients is that by injecting a novel mod-RNA therapeutic that modulates the IFN-1 signaling pathway, we reduced levels of cardiac damage, as evidenced by lower troponin, and improved cardiac function, as measured by higher left ventricular ejection fraction.”
As part of its ongoing research, Dr. Swirski’s team is collaborating with Lior Zangi, PhD, Associate Professor of Medicine (Cardiology), and Genetics and Genomic Sciences, at the Icahn school of Medicine at Mount Sinai, to investigate the use of a safe and effective systemic delivery method of the mod-RNA therapeutic to the heart’s muscle cells, instead of the direct injection method used in its proof-of-concept study. Additional work is focused on the pro-dendritic cell 3 itself: why is it so susceptible to influenza and how could its protective capacity be fully harnessed to potentially minimize heart damage exacerbated by cardiovascular disease?
“Pathogens are constantly emerging and evolving, which means our strategies to combat them must evolve as well,” says Dr. Swirski. “Better understanding of influenza pathogenesis and immune pathways that are activated throughout the body will help fuel the next stage of advanced care.”
This study was principally supported by the following grants from the National Heart, Lung, and Blood Institute and the Charles H. Revson Foundation: P01HL131478, P01 HL142494, R01 HL178835, K99 HL177314, and 24-29.
Mount Sinai Is a World Leader in Cardiology and Heart Surgery
Mount Sinai Fuster Heart Hospital at The Mount Sinai Hospital ranks No. 2 nationally for cardiology, heart, and vascular surgery, according to U.S. News & World Report®. It also ranks No. 1 in New York and No. 6 globally according to Newsweek’s “The World’s Best Specialized Hospitals.”
It is part of Mount Sinai Health System, which is New York City's largest academic medical system, encompassing seven hospitals, a leading medical school, and a vast network of ambulatory practices throughout the greater New York region. We advance medicine and health through unrivaled education and translational research and discovery to deliver care that is the safest, highest-quality, most accessible and equitable, and the best value of any health system in the nation. The Health System includes approximately 9,000 primary and specialty care physicians; 10 free-standing joint-venture centers throughout the five boroughs of New York City, Westchester, Long Island, and Florida; and 48 multidisciplinary research, educational, and clinical institutes. Hospitals within the Health System are consistently ranked by Newsweek’s® “The World’s Best Smart Hospitals” and by U.S. News & World Report's® “Best Hospitals” and “Best Children’s Hospitals.” The Mount Sinai Hospital is on the U.S. News & World Report's® “Best Hospitals” Honor Roll for 2025-2026.
For more information, visit https://www.mountsinai.org or find Mount Sinai on Facebook, Instagram, LinkedIn, X, and YouTube.
END
PROVIDENCE, R.I. [Brown University] — A long-standing Medicare policy meant to manage rehabilitation services in nursing homes may keep older Americans in hospitals longer than necessary without improving patient health or saving Medicare money, new research finds.
Established in 1965, the rule was intended to manage the use of skilled nursing facilities, which provide short-term medical and rehabilitative care to Medicare beneficiaries. Known as the “three-day rule,” it requires patients to spend at least three consecutive ...
About The Study: In this study, individuals with autism spectrum disorder, intellectual disability, or cerebral palsy experienced higher mortality from a range of causes compared with the general population in youth and young adulthood. Mortality among these groups is difficult to ascertain using death certificates alone, since ICD-10 codes for these disabilities were rarely listed. These findings can inform public health and health care strategies to understand and prevent health disparities and excess mortality associated with developmental disabilities.
Corresponding ...
About The Study: In this meta-analysis, the most credible risk factors associated with development of childhood food allergy are a combination of major and minor risk factors, including early allergic conditions (atopic march/diathesis), delayed allergen introduction, genetics, antibiotic exposure, demographic factors, and birth-related variables.
Corresponding Author: To contact the corresponding author, Derek K. Chu, email chudk@mcmaster.ca.
To access the embargoed study: Visit our For The Media website ...
About The Study: This cross-sectional study of 4,043 registered nurses (RNs) who recently left a hospital staff nurse job found opportunities for reattracting an existing RN workforce if hospitals are willing to address organizational issues driving RNs away. Many nonretired RNs, particularly those not currently employed, reported being very likely to return to work. The top factors to increase their likelihood of returning were adequate staffing, flexible scheduling, and better wages or benefits.
Corresponding Author: To ...
A new study from McMaster University involving 2.8 million children around the world has revealed the most important early-life factors that influence whether a child becomes allergic to food.
The study, one of the largest of its kind to examine food allergies, furthers our understanding of how allergies develop, concluding that a combination of genetic, environmental, microbial and social factors influence allergies, rather than a single cause.
To come to their findings, researchers carried out a systematic review and meta-analysis of 190 studies on childhood food allergy, including those that confirmed allergy using gold-standard food challenge testing. The study, published ...
A major study by UCL and Fondazione IRCCS Istituto Nazionale dei Tumori in Milan (INT) researchers has for the first time shown in detail how far children’s cancer has spread at diagnosis in a way that can be compared between countries.
While poorer survival following late-stage diagnosis is well recognised, the study is the first to show that differences in tumour stage at diagnosis may explain why childhood cancer survival varies between some European regions and tumour types.
Published in JAMA Network Open, the researchers analysed ...
In remembrance of Peer Bork
In a new study published in Cell, scientists in the Bork Group at EMBL Heidelberg reveal that microbes living in similar habitats are more alike than those simply inhabiting the same geographical region. By analysing tens of thousands of metagenomes, the team found that while most microbes adapt to a specific ecosystem, a rarer subset known as ‘generalists’ can thrive across very different habitats.
Known for being ecologically tolerant, generalists are capable of ...
Pancreatic cancer has a lot of nerve. Notoriously tricky to detect, the disease also often resists traditional therapy. So, researchers are urgently looking for new ways to disrupt tumor formation. Though scientists know that the nervous system can help cancer spread, its role in the disease’s earliest stages remains unclear. “One phenomenon that is known is called perineural invasion,” says Jeremy Nigri, a postdoc in Professor David Tuveson’s lab at Cold Spring Harbor Laboratory (CSHL). “This means cancer cells will migrate within the nerve and use the nerve as a way to metastasize.”
Now, Nigri and his colleagues at CSHL have discovered ...
Contact:
Rachel Peifer
rpeifer@crohnscolitisfoundation.org
Intermittent Fasting Cut Crohn’s Disease Activity by 40% and Halved Inflammation in Randomized Clinical Trial
First study of time-restricted feeding in people with IBD suggests a role in long-term remission
February 9, 2026 — A new randomized controlled study funded by the Crohn’s & Colitis Foundation found that time-restricted feeding—a form of intermittent fasting—significantly reduced symptomatic disease activity and systematic inflammation in adults with Crohn’s ...
PLYMOUTH MEETING, PA [February 9, 2026] — New research in the February 2026 issue of JNCCN—Journal of the National Comprehensive Cancer Network found that incorporating information from prostate-specific membrane antigen (PSMA) PET/CT scans may be able to predict progression-free survival (PFS) and guide treatment planning in patients with rising prostate-specific antigen (PSA) levels following removal of the prostate.
The researchers used retrospective clinical data from 113 patients treated for prostate ...
